Individualizing Management in T2D with CKD

Share

Program Content

Activities

  • Management of T2D and CKD
    How Should We Individualize Management for Patients With Type 2 Diabetes and CKD?
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 14, 2022

    Expires: September 13, 2023

  • Management in T2D with CKD
    Individualizing Management in T2D With CKD
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 21, 2022

    Expires: September 20, 2023

  • Management in T2D with CKD
    Individualizing Management in T2D With CKD
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 21, 2022

    Expires: September 20, 2023

Faculty

cover img faculity

Vivian A. Fonseca, MD, FRCP

Professor of Medicine and Pharmacology
Assistant Dean for Clinical Research
Tullis Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences center
New Orleans, Louisiana

Provided by

ProCE Banner

Supporters

Bayer HealthCare Pharmaceuticals Inc.

Boehringer Ingelheim and Eli Lilly